Showing 8441-8450 of 21412 results for "".
Diabetes Alert Day: Spreading Awareness & Education
https://reachmd.com/programs/diabetes-discourse/diabetes-alert-day-spreading-awareness-education/13531/With Diabetes Alert Day around the corner, what do we need to know about this campaign?Using CGMs and Insulin Pumps to Treat Pediatric Patients with T1D
https://reachmd.com/programs/diabetes-discourse/using-cgms-and-insulin-pumps-to-treat-pediatric-patients-with-t1d/16366/Tune in to learn more about some of the latest technologies used to treat pediatric patients with type 1 diabetes.Preventive Heart Disease Therapies for Diabetics
https://reachmd.com/programs/clinicians-roundtable/preventive-heart-disease-therapies-for-diabetics/1585/People with diabetes are two to four times more likely to develop cardiovascular disease. How can you help your patients reduce the odds of getting cardiovascular disease? Join host Larry Kaskel interview Cleveland Clinic's Stanely Hazen.The Doctor and the Mother: Treating Neonatal Diabetes
https://reachmd.com/programs/clinicians-roundtable/the-doctor-and-the-mother-treating-neonatal-diabetes/1692/Dr. Louis Philipson, from the University of Chicago School of Medicine, discusses the treatment of Neonatal Diabetes in context of a special case involving patient Lily Jaffe. Lilly's mother, Laurie Jaffe, a strong advocate for research and advancement in the treatment of this disease, participatesDrug Delivery Systems in the Management of Diabetes
https://reachmd.com/programs/diabetes-discourse/drug-delivery-systems-in-the-management-of-diabetes/4844/New drug delivery technologies are changing one of the key therapeutic challenges of insulin delivery in the management of diabetes. Join guest host Dr. Candis Morello and her guest, Dr. Brookie Best, assistant clinical professor of pharmacy and pediatrics at University of California San Diego, as tUnfair Treatment of Phase I Clinical Trial Subjects
https://reachmd.com/programs/clinicians-roundtable/unfair-treatment-of-phase-i-clinical-trial-subjects/3395/Dr. Jonathan Kimmelman, assistant professor of the Biomedical Research unit at McGill University, discusses with host Dr. Maurice Pickard what appears to be a ‘job' that may exploit the underclass in Phase 1 clinical studies. The poor in the studies are less likely to have access to the drugs when aHome Monitoring of Blood Sugar Did Not Improve Glycemic Control After 1 Year
https://reachmd.com/programs/the-jama-report/home-monitoring-blood-sugar-did-not-improve-glycemic-control-after-1-year/9653/A study in JAMA suggests that self-monitoring should not be routine in patients with type 2 diabetes who are not treated with insulinKey Insights from GRADE: Exploring Data on Glycemia Reduction in T2D
https://reachmd.com/programs/diabetes-discourse/key-insights-from-grade-exploring-data-on-glycemia-reduction-in-t2d/14619/What did we learn about treatment options for patients with type 2 diabetes from the GRADE study?Unanswered Questions in T1D: What Immunology and Islet Research Can Tell Us
https://reachmd.com/programs/diabetes-discourse/t1d-immunology-islet-research-unanswered-questions/67281/Despite advances in type 1 diabetes (T1D) research, key questions remain about disease progression, immune mechanisms, and the optimal timing of intervention. Here to explore how immunology and islet research could help address these knowledge gaps is Dr. Edward Phelps. He’s an Associate Professor iAACE Guidance in Action: When to Suspect and Treat Hypercortisolism in Adults with Diabetes
https://reachmd.com/programs/cme/aace-guidance-hypercortisolism-adults-diabetes/50073/Updated diabetes guidelines now recognize a new “other” category of diabetes linked to excess cortisol. This classification reflects emerging prevalence data showing that hypercortisolism may play a much larger role in diabetes development than previously understood. Let’s explore what these new gui